# Differential patterns of cross-protection against antigenically distinct variants in small animal models of SARS-CoV-2 infection

## TL;DR

The study shows that respiratory immunity from SARS-CoV-2 infection or vaccination can protect against new variants, even without specific antibodies.

## Contribution

The study reveals non-neutralizing antibody mechanisms of cross-protection against SARS-CoV-2 variants in small animal models.

## Key findings

- Immunity from infection or vaccination protects against antigenically distinct SARS-CoV-2 variants in the respiratory tract.
- Infection with a modern variant (XBB.1.5) does not prevent brain infection by the ancestral virus (WA1/2020) in mice.
- Previous infection with WA1/2020 does not protect against brain infection by XBB.1.5.

## Abstract

Continuous evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will likely necessitate periodic updates of vaccine composition. Based on a series of studies carried out in human ACE2 transgenic mice (K18-hACE2) and Syrian hamsters, we show that immunity at the respiratory tract, acquired through either previous infection or vaccination with an in-house live attenuated virus, offers protection against antigenically distinct variants in the absence of variant spike-specific neutralizing antibodies. Interestingly, immunity acquired through infection of a modern variant (XBB.1.5) was insufficient in preventing brain infection by the ancestral virus (WA1/2020) in K18-hACE2 mice. Similarly, previous infection with WA1/2020 did not protect against brain infection by XBB.1.5. Our results highlight the importance of immune components other than neutralizing antibodies in maintaining protection against new variants in the respiratory tract.